Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK
Mortality from cardiogenic shock attributable to acute myocardial infarction (AMI) approaches 50%, a figure that has not significantly improved in recent years. One of the only interventions found to improve mortality is urgent reperfusion of the culprit artery. However, 70% to 80% of patients with...
Gespeichert in:
Veröffentlicht in: | Archives of internal medicine (1960) 2020-10, Vol.180 (10), p.1280-1283 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Mortality from cardiogenic shock attributable to acute myocardial infarction (AMI) approaches 50%, a figure that has not significantly improved in recent years. One of the only interventions found to improve mortality is urgent reperfusion of the culprit artery. However, 70% to 80% of patients with ischemic cardiogenic shock have multivessel coronary artery disease, and optimal management of nonculprit lesions has been unclear. |
---|---|
ISSN: | 2168-6106 2168-6114 |
DOI: | 10.1001/jamainternmed.2020.3400 |